Artículos por temáticas

COVID-19 and anosmia in Tehran, Iran

Gilani S, Roditi R, Naraghi M.

Med Hypotheses. 2020 Aug;141:109757. doi: 10.1016/j.mehy.2020.109757. Epub 2020 Apr 23.

COVID-19: ICU delirium management during SARS-CoV-2 pandemic

Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW.

Version 2. Crit Care. 2020 Apr 28;24(1):176. doi: 10.1186/s13054-020-02882-x.

Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms

Troyer EA, Kohn JN, Hong S.

Brain Behav Immun. 2020 Jul;87:34-39. doi: 10.1016/j.bbi.2020.04.027. Epub 2020 Apr 13.

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?

Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA.

Neurologia. 2020 Apr;35(3):170-175. doi: 10.1016/j.nrl.2020.03.001. Epub 2020 Apr 6.

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G.

J Clin Med. 2020 May 11;9(5):1417. doi: 10.3390/jcm9051417.

COVID-19-Related Stroke

Hess DC, Eldahshan W, Rutkowski E.

Transl Stroke Res. 2020 Jun;11(3):322-325. doi: 10.1007/s12975-020-00818-9. Epub 2020 May 7.

Neurological manifestations in COVID-19 caused by SARS-CoV-2

Baig AM.

CNS Neurosci Ther. 2020 May;26(5):499-501. doi: 10.1111/cns.13372. Epub 2020 Apr 7.

Neurological Implications of COVID-19 Infections

Needham EJ, Chou SH, Coles AJ, Menon DK.

Neurocrit Care. 2020 Jun;32(3):667-671. doi: 10.1007/s12028-020-00978-4.

A validation of a self-administered screening test for Parkinson's disease

Leonardi M, Padovani A, McArthur JC.

Michele K.YorkaJared, F.Bengeb, Christine Huntera, Joseph Jankovica J Neurol. 2020 Jun;267(6):1573-1576. doi: 10.1007/s00415-020-09896-z. Epub 2020 May 20.

Brain Awareness Week, CoVID-19 infection and Neurological Sciences

Federico A.

Neurol Sci. 2020 Apr;41(4):747-748. doi: 10.1007/s10072-020-04338-0.

Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir

Mas Serrano M, Pérez-Sánchez JR, Portela Sánchez S, De La Casa-Fages B, Mato Jimeno V, Pérez Tamayo I, Grandas F.

J Neurol Sci. 2020 May 27;415:116944. doi: 10.1016/j.jns.2020.116944. Online ahead of print.

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B.

JAMA Neurol. 2020 Apr 10;77(6):1-9. doi: 10.1001/jamaneurol.2020.1127. Online ahead of print.

Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic

Özdağ Acarli AN, Samanci B, Ekizoğlu E, Çakar A, Şirin NG, Gündüz T, Parman Y, Baykan B.

Noro Psikiyatr Ars. 2020 May 1;57(2):154-159. doi: 10.29399/npa.26148. eCollection 2020 Jun.

Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19)

Baig AM, Sanders EC.

J Med Virol. 2020 Jun 3:10.1002/jmv.26105. doi: 10.1002/jmv.26105. Online ahead of print.

A review of pathophysiology and neuropsychiatric manifestations of COVID-19

Jasti M, Nalleballe K, Dandu V, Onteddu S.

J Neurol. 2021 Jun;268(6):2007-2012. doi: 10.1007/s00415-020-09950-w. Epub 2020 Jun 3.